GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) is expected to be issuing its Q2 2026 results before the market opens on Wednesday, July 29th. Analysts expect GE HealthCare Technologies to post earnings of $1.04 per share and revenue of $5.2644 billion for the quarter. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Parties can check the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, July 29, 2026 at 8:30 AM ET.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter in the prior year, the firm posted $1.01 earnings per share. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, analysts expect GE HealthCare Technologies to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
GE HealthCare Technologies Price Performance
NASDAQ:GEHC opened at $60.58 on Monday. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The stock has a market capitalization of $27.56 billion, a P/E ratio of 14.49, a P/E/G ratio of 1.65 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. The company’s 50-day simple moving average is $63.63 and its 200-day simple moving average is $71.14.
GE HealthCare Technologies Announces Dividend
Analysts Set New Price Targets
Several research firms have issued reports on GEHC. Royal Bank Of Canada initiated coverage on shares of GE HealthCare Technologies in a report on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 price target on the stock. HSBC decreased their price objective on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Mizuho dropped their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. BTIG Research reaffirmed a “buy” rating and set a $75.00 target price on shares of GE HealthCare Technologies in a research report on Monday, July 13th. Finally, Stifel Nicolaus set a $80.00 price target on GE HealthCare Technologies in a research note on Wednesday, April 29th. Ten equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $76.41.
Read Our Latest Research Report on GEHC
Key Headlines Impacting GE HealthCare Technologies
Here are the key news stories impacting GE HealthCare Technologies this week:
- Positive Sentiment: GE HealthCare reported preliminary second-quarter 2026 results and reaffirmed its full-year guidance, which suggests the business is still tracking in line with expectations and may be seeing momentum in key areas. GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
- Positive Sentiment: The company’s revenue outlook appears steady, with Q2 revenue guidance roughly in line with Wall Street estimates, and management has indicated that second-half performance could improve as cost pressures ease. Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
- Neutral Sentiment: GE HealthCare announced that CFO Jay Saccaro will step down, but the company framed the move as a transition rather than a crisis, which makes the near-term market impact uncertain. GE HealthCare CFO to step down
- Negative Sentiment: Ongoing securities-fraud investigations and shareholder-loss solicitations add legal uncertainty and can weigh on sentiment toward GEHC stock. GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- Negative Sentiment: Another law firm expanded a securities-fraud probe tied to prior disclosures, reinforcing investor concerns about possible litigation risk. Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- Negative Sentiment: GE HealthCare was downgraded by Zacks Research from “hold” to “strong sell,” which may add to selling pressure. Zacks Research downgrade
Insider Activity
In related news, insider Frank R. Jimenez acquired 1,750 shares of the firm’s stock in a transaction dated Thursday, April 30th. The stock was acquired at an average price of $60.45 per share, with a total value of $105,787.50. Following the acquisition, the insider directly owned 93,932 shares in the company, valued at $5,678,189.40. This represents a 1.90% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Peter J. Arduini bought 4,169 shares of the stock in a transaction dated Thursday, April 30th. The stock was bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the purchase, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought a total of 21,847 shares of company stock valued at $1,361,355 over the last quarter. Insiders own 0.36% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the stock. Transamerica Financial Advisors LLC boosted its position in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares in the last quarter. Zions Bancorporation National Association UT increased its holdings in shares of GE HealthCare Technologies by 125.1% during the 4th quarter. Zions Bancorporation National Association UT now owns 412 shares of the company’s stock valued at $34,000 after purchasing an additional 229 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in shares of GE HealthCare Technologies during the 4th quarter valued at approximately $34,000. Miller Capital Partners Inc. acquired a new position in shares of GE HealthCare Technologies in the 4th quarter valued at $38,000. Finally, Palisade Asset Management LLC acquired a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at $41,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.
About GE HealthCare Technologies
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Articles
- Five stocks we like better than GE HealthCare Technologies
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
